PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAucta Pharmaceuticals
Aucta Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
OxcarbazepineOxcarbazepine2022-11-302027
Epilepsy
,
Partial epilepsies
VigadroneVigabatrin2018-06-21
Epilepsy
,
Infantile spasms
,
Partial epilepsies
,
Complex partial epilepsy
MotpolyLacosamide2023-05-04
Epilepsy
,
Lennox gastaut syndrome
,
Partial epilepsies
,
Tonic-clonic epilepsy
ArformoterolArformoterol2025-02-03
Chronic bronchitis,
Pulmonary emphysema,
Bronchial spasm
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Histone-arginine methyltransferase carm1
drug interactions
Surlorian
depression
,
cognitive dysfunction
,
major depressive disorder
,
depressive disorder
,
neurocognitive disorders
,
hiv
,
sarcoma
,
acquired immunodeficiency syndrome
,
kaposi sarcoma
,
human herpesvirus 8
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use